Copyright Reports & Markets. All rights reserved.

Global AI Drug Design Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Drug Design by Type
    • 1.3.1 Overview: Global AI Drug Design Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Drug Design Consumption Value Market Share by Type in 2025
    • 1.3.3 Therapy Research
    • 1.3.4 Design and Development
    • 1.3.5 Others
  • 1.4 Global AI Drug Design Market by Application
    • 1.4.1 Overview: Global AI Drug Design Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer
    • 1.4.3 Cardiovascular Disease
    • 1.4.4 Others
  • 1.5 Global AI Drug Design Market Size & Forecast
  • 1.6 Global AI Drug Design Market Size and Forecast by Region
    • 1.6.1 Global AI Drug Design Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global AI Drug Design Market Size by Region, (2021-2032)
    • 1.6.3 North America AI Drug Design Market Size and Prospect (2021-2032)
    • 1.6.4 Europe AI Drug Design Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific AI Drug Design Market Size and Prospect (2021-2032)
    • 1.6.6 South America AI Drug Design Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa AI Drug Design Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Exscientia
    • 2.1.1 Exscientia Details
    • 2.1.2 Exscientia Major Business
    • 2.1.3 Exscientia AI Drug Design Product and Solutions
    • 2.1.4 Exscientia AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Exscientia Recent Developments and Future Plans
  • 2.2 PathAI
    • 2.2.1 PathAI Details
    • 2.2.2 PathAI Major Business
    • 2.2.3 PathAI AI Drug Design Product and Solutions
    • 2.2.4 PathAI AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 PathAI Recent Developments and Future Plans
  • 2.3 Tempus
    • 2.3.1 Tempus Details
    • 2.3.2 Tempus Major Business
    • 2.3.3 Tempus AI Drug Design Product and Solutions
    • 2.3.4 Tempus AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Tempus Recent Developments and Future Plans
  • 2.4 Aria Pharmaceuticals
    • 2.4.1 Aria Pharmaceuticals Details
    • 2.4.2 Aria Pharmaceuticals Major Business
    • 2.4.3 Aria Pharmaceuticals AI Drug Design Product and Solutions
    • 2.4.4 Aria Pharmaceuticals AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Aria Pharmaceuticals Recent Developments and Future Plans
  • 2.5 BenchSci
    • 2.5.1 BenchSci Details
    • 2.5.2 BenchSci Major Business
    • 2.5.3 BenchSci AI Drug Design Product and Solutions
    • 2.5.4 BenchSci AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 BenchSci Recent Developments and Future Plans
  • 2.6 Antidote
    • 2.6.1 Antidote Details
    • 2.6.2 Antidote Major Business
    • 2.6.3 Antidote AI Drug Design Product and Solutions
    • 2.6.4 Antidote AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Antidote Recent Developments and Future Plans
  • 2.7 AiCure
    • 2.7.1 AiCure Details
    • 2.7.2 AiCure Major Business
    • 2.7.3 AiCure AI Drug Design Product and Solutions
    • 2.7.4 AiCure AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AiCure Recent Developments and Future Plans
  • 2.8 Atomwise
    • 2.8.1 Atomwise Details
    • 2.8.2 Atomwise Major Business
    • 2.8.3 Atomwise AI Drug Design Product and Solutions
    • 2.8.4 Atomwise AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Atomwise Recent Developments and Future Plans
  • 2.9 Envisagenics
    • 2.9.1 Envisagenics Details
    • 2.9.2 Envisagenics Major Business
    • 2.9.3 Envisagenics AI Drug Design Product and Solutions
    • 2.9.4 Envisagenics AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Envisagenics Recent Developments and Future Plans
  • 2.10 Sherlock
    • 2.10.1 Sherlock Details
    • 2.10.2 Sherlock Major Business
    • 2.10.3 Sherlock AI Drug Design Product and Solutions
    • 2.10.4 Sherlock AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Sherlock Recent Developments and Future Plans
  • 2.11 Deep Genomics
    • 2.11.1 Deep Genomics Details
    • 2.11.2 Deep Genomics Major Business
    • 2.11.3 Deep Genomics AI Drug Design Product and Solutions
    • 2.11.4 Deep Genomics AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Deep Genomics Recent Developments and Future Plans
  • 2.12 Benevolent
    • 2.12.1 Benevolent Details
    • 2.12.2 Benevolent Major Business
    • 2.12.3 Benevolent AI Drug Design Product and Solutions
    • 2.12.4 Benevolent AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Benevolent Recent Developments and Future Plans
  • 2.13 Iktos
    • 2.13.1 Iktos Details
    • 2.13.2 Iktos Major Business
    • 2.13.3 Iktos AI Drug Design Product and Solutions
    • 2.13.4 Iktos AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Iktos Recent Developments and Future Plans
  • 2.14 AlmirallShare
    • 2.14.1 AlmirallShare Details
    • 2.14.2 AlmirallShare Major Business
    • 2.14.3 AlmirallShare AI Drug Design Product and Solutions
    • 2.14.4 AlmirallShare AI Drug Design Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AlmirallShare Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Drug Design Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Drug Design by Company Revenue
    • 3.2.2 Top 3 AI Drug Design Players Market Share in 2025
    • 3.2.3 Top 6 AI Drug Design Players Market Share in 2025
  • 3.3 AI Drug Design Market: Overall Company Footprint Analysis
    • 3.3.1 AI Drug Design Market: Region Footprint
    • 3.3.2 AI Drug Design Market: Company Product Type Footprint
    • 3.3.3 AI Drug Design Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Drug Design Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Drug Design Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Drug Design Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Drug Design Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Drug Design Consumption Value by Type (2021-2032)
  • 6.2 North America AI Drug Design Market Size by Application (2021-2032)
  • 6.3 North America AI Drug Design Market Size by Country
    • 6.3.1 North America AI Drug Design Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Drug Design Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Drug Design Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Drug Design Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Drug Design Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Drug Design Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Drug Design Market Size by Country
    • 7.3.1 Europe AI Drug Design Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Drug Design Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Drug Design Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Drug Design Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Drug Design Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Drug Design Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Drug Design Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Drug Design Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Drug Design Market Size by Region
    • 8.3.1 Asia-Pacific AI Drug Design Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Drug Design Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Drug Design Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Drug Design Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Drug Design Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Drug Design Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Drug Design Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Drug Design Consumption Value by Type (2021-2032)
  • 9.2 South America AI Drug Design Consumption Value by Application (2021-2032)
  • 9.3 South America AI Drug Design Market Size by Country
    • 9.3.1 South America AI Drug Design Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Drug Design Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Drug Design Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Drug Design Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Drug Design Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Drug Design Market Size by Country
    • 10.3.1 Middle East & Africa AI Drug Design Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Drug Design Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Drug Design Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Drug Design Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Drug Design Market Drivers
  • 11.2 AI Drug Design Market Restraints
  • 11.3 AI Drug Design Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Drug Design Industry Chain
  • 12.2 AI Drug Design Upstream Analysis
  • 12.3 AI Drug Design Midstream Analysis
  • 12.4 AI Drug Design Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global AI Drug Design market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    AI drug design refers to the use of artificial intelligence and computational methods to discover, design, and develop new pharmaceutical drugs. By employing machine learning algorithms, AI Drug Design can analyze vast amounts of chemical and biological data, predict drug-target interactions, generate virtual compound libraries, and propose potential drug candidates. It aims to accelerate the drug discovery process, improve the success rate of candidate molecules, and facilitate the development of more effective and targeted medications.
    This report is a detailed and comprehensive analysis for global AI Drug Design market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global AI Drug Design market size and forecasts, in consumption value ($ Million), 2021-2032
    Global AI Drug Design market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global AI Drug Design market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global AI Drug Design market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for AI Drug Design
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global AI Drug Design market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise, Envisagenics, Sherlock, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    AI Drug Design market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Therapy Research
    Design and Development
    Others
    Market segment by Application
    Cancer
    Cardiovascular Disease
    Others
    Market segment by players, this report covers
    Exscientia
    PathAI
    Tempus
    Aria Pharmaceuticals
    BenchSci
    Antidote
    AiCure
    Atomwise
    Envisagenics
    Sherlock
    Deep Genomics
    Benevolent
    Iktos
    AlmirallShare
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe AI Drug Design product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of AI Drug Design, with revenue, gross margin, and global market share of AI Drug Design from 2021 to 2026.
    Chapter 3, the AI Drug Design competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Design market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Design.
    Chapter 13, to describe AI Drug Design research findings and conclusion.

    Buy now